Article
Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
Cancer research - 1 Jul 2009
Pomerantz Mark M, Beckwith Christine A, Regan Meredith M, Wyman Stacia K, Petrovics Gyorgy, Chen Yongmei, Hawksworth Dorota J, Schumacher Fredrick R, Mucci Lorelei, Penney Kathryn L, Stampfer Meir J, Chan Jennifer A, Ardlie Kristin G, Fritz Brian R, Parkin Rachael K, Lin Daniel W, Dyke Michelle, Herman Paula, Lee Steve, Oh William K, Kantoff Philip W, Tewari Muneesh, McLeod David G, Srivastava Shiv, Freedman Matthew L
Abstract excerpt
Polymorphisms at 8q24 are robustly associated with prostate cancer risk. The risk variants are located in nonprotein coding regions and their mechanism has not been fully elucidated. To further dissect the function of this locus, we tested two hypotheses: (a) unannotated microRNAs (miRNA) are transcribed in the region, and (b) this region is a cis-acting enhancer. Using next generation sequencing, 8q24 risk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
